BC

BioAtla

BCAB·NASDAQSan Diego CAFounded 200780 employees
Micro CapbiotechPublicOncology
Platform: CAB ADC
Market Cap
$0.1B
All Drugs
2
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (BCAB)
Loading BCAB stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
PolatuximabBCA-7937Phase 12VaccineC5ALKiEwing Sarcoma
CapibrutinibBCA-1548Phase 34Fusion ProteinMALT1CGRPantAlzheimer's
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)
2026-05-15
Capibrutinib Ph3 Readout
Alzheimer's
Ph3 Readout
2026-08-07
Polatuximab Interim
Ewing Sarcoma
Interim
2028-05-23
Capibrutinib Ph3 Readout
Alzheimer's
Ph3 Readout
2030-04-01
Polatuximab Interim
Ewing Sarcoma
Interim